MedTrace Logo

Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

NCT05440487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 489

Last updated 2022-10-21

No results posted yet for this study

Summary

This is a prospective, multicenter, non-interventional study. Findings are analyzed using epidemiological methods.

Conditions

  • Chronic Iron Overload

Interventions

OTHER

Iron chelator

There is no treatment allocation. Patients administered approved Iron chelators by prescription that have started before inclusion of the patient into the study will be enrolled.

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-15
Primary Completion
2021-10-29
Completion
2021-10-29

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05440487 on ClinicalTrials.gov